Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Bielekova B, Howard T, Packer AN, Richert N, Blevins G, Ohayon J, Waldmann TA, McFarland HF, Martin R Arch Neurol. 2009 Apr; 66(4):483-9. PMID: 19364933. Abstract CommentRecommendBookmarkWatch